drugset / Trial / NCT00754442
Suspected Deficient Activation of Vitamin D in Patients With Secondary Hyperparathyroidism
Non-randomizedParallel-groupOpen-labelDiagnostic
Summary
The purpose of this study is to determine if a reduction in the enzyme 1-hydroxylase, which activates Vitamin D, is the cause of overactivity of the parathyroid glands (called secondary hyperparathyroidism - normal blood calcium and elevated parathyroid hormone) in a selected group of young patients with normal kidney function.
Timeline
- Start
- 2007-02
- Primary completion
- 2008-08
- Completion
- 2008-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Teriparatide | Protein / enzyme biologic | 12 unknown | Intravenous |